-
Markeder
-
Aksjer
Sustainable finance2025 Euronext ESG Trends ReportLes merA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indekser
Access the white paperInvesting in the future of Europe with innovative indicesLes merThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETF-er
The European market place for ETFsEuronext ETF EuropeLes merInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Fond
-
Obligasjoner
European Defence BondsGroupe BPCE lists the first bondLes merFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Strukturerte produkter
-
Derivater
Where European Government Bonds Meet the FutureFixed Income derivativesLes merTrade mini bond futures on main European government bonds
-
Råvarer
- Oversikt
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Levering og oppgjør
- Spesifikasjoner og ordninger
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesLes merEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Ressurser
Designed to help students navigate the complexities of financial marketsEuronext Trading gameLes merJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
THROMBOGENICS
Identification
Operation
4.50 euros
Inscription au Marché Continu - Groupe A1 - Compartiment C
- Un maximum de 35 millions EUR d’actions nouvelles avec strips VVPR, jouissance 01-06-2006, pouvant être augmenté d’un max. de EUR 10 millions à 45 EUR millions dans le cas d’une souscription importante, qui seront offertes en souscription publique du 22 juin 2006 au 5 juillet 2006 inclus, sauf clôture anticipée.
Ces titres figureront à la cote sous la dénomination ThromboGenics avec la mention WI jusqu’au 11 juillet 2006 inclus (When Issued : voir ci-après).
- 14.362.527 actions existantes de la société ThromboGenics.
- à une date à fixer ultérieurement : un max. de 1.897.655 actions nouvelles à provenir de l’exercice éventuel de warrants offerts par ThromboGenics Ltd dans le cadre des plans de warrants.
N.B. : En attendant la livraison matérielle des actions, les liquidations s’effectueront uniquement par transfert de compte à compte.